NCT04640753 Peroral Endoscopic Myotomy for the Treatment of Achalasia
| NCT ID | NCT04640753 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Methodist Health System |
| Condition | Achalasia |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2019-02-06 |
| Primary Completion | 2027-02-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2019-02-06 with a primary completion date of 2027-02-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
There will be a retrospective chart review for patients who underwent endoscopic procedures and POEM from 06/2016 - 01/2019 \& a prospective chart review will be performed for patients who will undergo endoscopic procedures and POEM from 02/2019 - 06/2021
Eligibility Criteria
Inclusion Criteria: * Any discharged patient who has undergone clinically indicated and/or standard of care POEM for the treatment of Achalasia from 6/2016 to 6/2021. * Above or equal to 18 years of age Exclusion Criteria: * Any patient who has not undergone POEM for the treatment of Achalasia. * Below 18 years of age
Contact & Investigator
Prashant Kedia, M.D.
PRINCIPAL INVESTIGATOR
The Methodist Hospital Research Institute
Frequently Asked Questions
Who can join the NCT04640753 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Achalasia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04640753 currently recruiting?
Yes, NCT04640753 is actively recruiting participants. Contact the research team at clinicalresearch@mhd.com for enrollment information.
Where is the NCT04640753 trial being conducted?
This trial is being conducted at Dallas, United States.
Who is sponsoring the NCT04640753 clinical trial?
NCT04640753 is sponsored by Methodist Health System. The principal investigator is Prashant Kedia, M.D. at The Methodist Hospital Research Institute. The trial plans to enroll 200 participants.